MTBC Medical Transcription Billing Corp

CareCloud to Showcase its Generative AI Solutions and Tech-Enabled RCM at the 2024 HIMSS Conference and Exhibition

CareCloud to Showcase its Generative AI Solutions and Tech-Enabled RCM at the 2024 HIMSS Conference and Exhibition

SOMERSET, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced its participation in the HIMSS Global Health Conference and Exhibition, taking place from March 11-15 in Orlando, Florida. Positioned at booth 5281, CareCloud will use this opportunity to showcase its state-of-the-art generative AI solutions, alongside its other products and services for physician practices.

HIMSS is expected to draw over 40,000 healthcare professionals from various sectors of the health ecosystem and will focus on innovation in the areas of digital health transformation, applied artificial intelligence, cybersecurity, emerging technologies, patient safety and quality, among others. The exhibit floor will feature groundbreaking technology and will offer attendees hands-on interactions and access to thought leaders at specialty pavilions.

“Central to CareCloud’s presence at the conference will be showcasing our latest AI-powered subjective, objective, assessment, and plan (“SOAP”) notes, called CareCloud cirrusAI Notes, which is poised to redefine healthcare documentation for our clients,” said Chief Technology Officer Adeel Sarwar. “This innovative tool ensures real-time transcription of provider-patient interactions, while seamlessly generating accurate clinical notes and providing essential support in diagnosis, prescription, procedures, and care planning, all in a HIPAA-compliant environment. We believe that CareCloud cirrusAI Notes can help reduce time spent on charting by up to 20%, while optimizing workflow efficiency and empowering its users to prioritize the delivery of patient care.”

CareCloud cirrusAI Notes runs ambiently in the background during patient visits, identifying the key parts of the conversation and medical terms, while creating a clinical note for the doctor’s review. Once accepted, this note is seamlessly and securely saved in the patient’s chart within the EHR.

CareCloud cirrusAI Notes will be another addition to the Company’s generative AI suite, called cirrusAI, which is designed to optimize clinical, financial, and operational outcomes. With four integral features – CareCloud cirrusAI Guide, CareCloud cirrusAI Chat, CareCloud cirrusAI Appeals, and CareCloud cirrusAI Notes – the generative AI suite harnesses the power of Google’s Vertex AI’s generative AI tools to furnish real-time, evidence-based recommendations and personalized suggestions to healthcare providers. Designed to align seamlessly with a variety of EHR systems, it holds the promise of enhancing diagnosis accuracy, treatment planning, and revenue cycle management.

“We look forward to showcasing our generative AI solutions at HIMSS,” said Chief Sales Officer Justin Pierce. “We will also be sharing more about our other industry-leading solutions including our EHR product, our Concierge RCM service, CareCloud Force and CareCloud Wellness.” 

CareCloud will be represented at HIMSS by its President and CEO Hadi Chaudhry, Chief Sales Officer Justin Pierce, Chief Technology Officer Adeel Sarwar, and others.

To learn more about CareCloud’s comprehensive suite of technology-enabled services and solutions, visit . 

About CareCloud 

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at . 

Follow CareCloud on ,  and . 

SOURCE CareCloud 

Investor Contact: 

Bill Korn 

 



EN
11/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medical Transcription Billing Corp

 PRESS RELEASE

CareCloud Reports Second Quarter 2025 Results

CareCloud Reports Second Quarter 2025 Results Delivers first quarter of positive GAAP EPS in Company’s history since going public, announces initial results from AI Initiative SOMERSET, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the quarter ended June 30, 2025. CareCloud’s strategic execution, AI-driven innovation, and disciplined financial management has positioned the Company for sustained profitability and long-term growth. Man...

 PRESS RELEASE

CareCloud’s TalkEHR Approved for Use by Critical Access Hospitals, Unl...

CareCloud’s TalkEHR Approved for Use by Critical Access Hospitals, Unlocking $1.5B+ Inpatient Market SOMERSET, N.J., Aug. 04, 2025 (GLOBE NEWSWIRE) --  (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of healthcare technology and generative AI solutions, today announced that its electronic health record (“EHR”) platform has achieved ONC Health IT Certification specifically for Critical Access Hospitals (“CAHs”), a milestone officially granted on August 1, 2025. This certification marks CareCloud’s strategic entry into the inpatient EHR market, unlocking access to ...

 PRESS RELEASE

CareCloud Announces Preferred Stock Dividend Payments

CareCloud Announces Preferred Stock Dividend Payments SOMERSET, N.J., July 25, 2025 (GLOBE NEWSWIRE) -- (the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the “Board”) has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”) and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”) for July, August and September 2025. The ...

 PRESS RELEASE

CareCloud Launches AI-Driven, Fully Integrated Dermatology EHR to Stre...

CareCloud Launches AI-Driven, Fully Integrated Dermatology EHR to Streamline Workflows and Enhance Patient Care SOMERSET, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, today announced the launch of its fully integrated, AI-driven dermatology EHR, designed to streamline clinical workflows and collections, while enhancing patient engagement and improving financial outcomes for dermatology practices. "Our fully integrated, AI-dri...

 PRESS RELEASE

CareCloud to Announce Second Quarter 2025 Results on August 5, 2025

CareCloud to Announce Second Quarter 2025 Results on August 5, 2025 SOMERSET, N.J., July 16, 2025 (GLOBE NEWSWIRE) --  (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the second quarter ended June 30, 2025 before the market opens on Tuesday, August 5, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch